TREATMENT OF EXPERIMENTAL TOTAL HYPHEMAS WITH INTRAOCULAR FIBRINOLYTIC AGENTS. II.
D003318:Corneal Opacity; D003850:Deoxyribonuclease I; D005128:Eye Diseases; D005131:Eye Injuries; D005341:Fibrinolysin; D005343:Fibrinolytic Agents; D006470:Hemorrhage; D006988:Hyphema; D007429:Intraocular Pressure; D008775:Methylprednisolone; D011817:Rabbits; D012106:Research; D013299:Streptodornase and Streptokinase; D013300:Streptokinase; D014065:Tonometry, Ocular
D005343:Fibrinolytic Agents; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase; D005341:Fibrinolysin; D008775:Methylprednisolone
CORNEAL OPACITY; EXPERIMENTAL LAB STUDY; EYE INJURIES; FIBRINOLYSIN; HEMORRHAGE; INTRAOCULAR PRESSURE; METHYLPREDNISOLONE; RABBITS; STREPTODORNASE AND STREPTOKINASE